Anil Bidkar
@anilbidkar1
Followers
55
Following
386
Media
0
Statuses
57
Joined January 2014
RT @urotoday: A combination of a CD46-targeted antibody-drug conjugate and a radioimmunotherapy agent for the treatment of #ProstateCancer.….
0
6
0
RT @freddyeescorcia: Had fun collaborating with Ravi Patel (@RPatelMDPHD) & Steve Adler (@IRPatNIH) on this commentary highlighting Rob Fla….
0
3
0
RT @urotoday: Effective treatment of disseminated #ProstateCancer using CD46-targeted 225Ac therapy. #AuthorCommentary New hope for PSMA-ne….
0
5
0
RT @flavell_rob: Congrats to @anilbidkar1 on leading this work integrating alpha particle microdosimetry with therapeutic efficacy, and dem….
0
1
0
RT @urotoday: Effective treatment of disseminated #ProstateCancer using CD46-targeted 225Ac therapy. #AuthorCommentary New hope for PSMA-ne….
0
3
0
Exciting news from Flavell Lab(@flavell_rob)! Our latest study on CD46-targeted Actinium-225 alpha particle therapy for disseminated prostate cancer is now online in Clinical Cancer Research. Read it @CCR_AACR: #ProstateCancer #Ac225 #CD46 #Theranostics.
Dr. @anilbidkar1 and team highlight that [225Ac]Macropa-PEG4-YS5 holds the potential for clinical translation for metastatic #ProstateCancer. 🔗 Check out their study in @CCR_AACR:
1
1
10
RT @urotoday: At the #2024PSMAConference, @flavell_rob discussed the promise of antibody-based radiopharmaceuticals for prostate cancer, hi….
0
5
0
RT @UCSFimaging: New in #Theranostics from @UCSFimaging's Drs. Anil Bidkar (@anilbidkar1), Luann Zerefa, Surekha Yadav (@shiningsurekha), H….
0
4
0
RT @TejalADesai: Excited that our new paper is out! Led by Deblin Jana @brownengin @DesaiLabUCSF in collaboration with @flavell_rob @UCSFim….
0
8
0
RT @UCSFimaging: We're excited to see everyone at #SNMMI24! @UCSFimaging's #postdoc Anil Bidkar (@anilbidkar1) will be presenting about usi….
0
4
0
RT @flavell_rob: Congrats to @anilbidkar1 @shiningsurekha and co-authors on the timely review on Actinium-225 targeted alpha particle thera….
0
2
0
RT @UCSFimaging: Innovative research from @UCSFImaging's Drs. Shalini Chopra, Kondapa Naidu Bobba, Youngho Seo, @flavell_rob, @mikeevans_uc….
0
1
0
RT @biopatrika: 🔬 Dr. K Naidu Bobba (@knaidubobba), the first author from Prof. Robert Flavell's lab (@flavell_rob ) at @UCSFimaging @UCSF….
0
2
0
RT @UCSFimaging: "Henry VanBrocklin is a deserving recipient of the @SNM_MI Aebersold Award," says @UCSFImaging Chair Chris Hess (@NeuroDx)….
0
1
0
RT @SNM_MI: #SNMMI23 Abstract Highlight: New radiopharmaceutical therapy target identified for metastatic #BladderCancer. .
0
5
0
RT @SNM_MI: Congratulations are in order for Henry VanBrocklin, PhD, FSNMMI, FSRS, the 2023 recipient of the prestigious SNMMI Paul C. Aebe….
0
10
0
RT @flavell_rob: Congrats @NiruMeher on this article! Nice discussion on the intersection of PSMA theranostics and nanotechnology.
0
2
0
RT @UCSFimaging: .@UCSFImaging's Dr. Kondapa Naidu Bobba (@knaidubobba) is first author of "Evaluation of 134Ce/134La as a PET Imaging Ther….
0
4
0
RT @flavell_rob: Congrats @PaulKlauser @WangUCSF @knaidubobba @mikeevans_ucsf! Great example of using new technologies to enhance #theranos….
0
1
0
RT @UCSFimaging: A radioimmunotherapy agent based on the YS5 antibody "suppressed the growth of cell-derived & patient-derived #xenografts,….
0
3
0